SIMCERE PHARMACEUTICAL GROUP's ticker is SCR and the CUSIP is 82859P104. A total of 3 filers reported holding SIMCERE PHARMACEUTICAL GROUP in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2012 | $804,000 | -8.6% | 100,000 | 0.0% | 0.03% | -11.1% |
| Q3 2012 | $880,000 | -2.0% | 100,000 | 0.0% | 0.04% | -10.0% |
| Q2 2012 | $898,000 | -4.9% | 100,000 | 0.0% | 0.04% | -7.0% |
| Q1 2012 | $944,000 | +0.4% | 100,000 | 0.0% | 0.04% | 0.0% |
| Q4 2011 | $940,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Loeb Offshore Management LP | 50,575 | $488,000 | 0.14% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 109,723 | $1,054,000 | 0.02% |
| SG Americas Securities, LLC | 134,813 | $1,294,000 | 0.01% |
| Baillie Gifford | 24,400 | $236,000 | 0.00% |
| MORGAN STANLEY | 1,143 | $11,000 | 0.00% |
| BARCLAYS PLC | 10,758 | $97,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,700 | $112,000 | 0.00% |
| UBS AG | 2,248 | $22,000 | 0.00% |
| US BANCORP \DE\ | 196 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,500 | $14,000 | 0.00% |